ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $4,176,000 | +64.9% | 44,930 | +5.6% | 0.02% | +60.0% |
Q3 2021 | $2,533,000 | +27.2% | 42,530 | +45.7% | 0.01% | +11.1% |
Q2 2021 | $1,991,000 | +297.4% | 29,192 | +304.0% | 0.01% | +200.0% |
Q1 2021 | $501,000 | -47.6% | 7,225 | -42.0% | 0.00% | -50.0% |
Q4 2020 | $957,000 | – | 12,456 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |